financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Iovance Biotherapeutics Names Corleen Roche as Chief Financial Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Iovance Biotherapeutics Names Corleen Roche as Chief Financial Officer
Jul 15, 2025 5:19 AM

07:49 AM EDT, 07/15/2025 (MT Newswires) -- Iovance Biotherapeutics ( IOVA ) said Tuesday it has appointed Corleen Roche as chief financial officer, effective Aug. 6.

Roche most recently served as CFO of CG Oncology (CGON).

Iovance shares were down 6% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Factbox-US deals blocked by regulators or facing intense scrutiny
Factbox-US deals blocked by regulators or facing intense scrutiny
Nov 15, 2024
(Reuters) - Tapestry abandoned its $8.5 billion bid for Michael Kors owner Capri after a judge blocked it following a lawsuit by the U.S. Federal Trade Commission (FTC), in the latest regulatory squeeze under the Biden administration. Here are other deals that have been terminated or face regulatory scrutiny: DEALS THAT HAVE BEEN TERMINATED DEAL DEAL VALUE CONTEXT JetBlue-Sp $3.8...
 SigmaTron International Names Frank Cesario as CFO
SigmaTron International Names Frank Cesario as CFO
Nov 15, 2024
11:48 AM EST, 11/14/2024 (MT Newswires) -- SigmaTron International ( SGMA ) appointed Frank Cesario as chief financial officer, effective Nov. 11. James Reiman resigned as CFO, effective Nov. 8, citing personal reasons, the company said Thursday in a regulatory filing. Cesario, 55, previously served as chief executive officer and acting CFO of Yunhong Green CTI ( YHGJ ) ....
 --Renasant Keeps Quarterly Dividend at $0.22 a Share; Payable Jan. 1 to Shareholders of Record as of Dec. 18
--Renasant Keeps Quarterly Dividend at $0.22 a Share; Payable Jan. 1 to Shareholders of Record as of Dec. 18
Nov 15, 2024
11:46 AM EST, 11/14/2024 (MT Newswires) -- Price: 36.83, Change: -0.18, Percent Change: -0.49 ...
 Factbox-US deals blocked by regulators or facing intense scrutiny
Factbox-US deals blocked by regulators or facing intense scrutiny
Nov 15, 2024
(Reuters) - Tapestry abandoned its $8.5 billion bid for Michael Kors owner Capri after a judge blocked it following a lawsuit by the U.S. Federal Trade Commission (FTC), in the latest regulatory squeeze under the Biden administration. Here are other deals that have been terminated or face regulatory scrutiny: DEALS THAT HAVE BEEN TERMINATED DEAL DEAL VALUE CONTEXT JetBlue-Sp $3.8...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved